Thorsten Hein is CEO of Bayer (Schweiz) AG and Vice President, Global AI-Enabled Commercial Transformation for Bayer Pharmaceuticals. He is a senior pharmaceutical executive with more than 25 years of P&L, major brand launch and business transformation experience across Europe and Asia-Pacific, including extensive leadership experience in Greater China. He is recognised for translating strategy into execution—building high-performing organisations, transforming established businesses and creating operating models that strengthen accountability, speed and commercial impact. Throughout his career, he has led pharmaceutical businesses serving diverse patient populations, customers and healthcare systems.
Across every market in which he has worked, he has actively contributed to health policy dialogue and helped shape the conditions for sustainable innovation and better patient outcomes.
In his global AI transformation role, Thorsten is shaping a future in which AI enables organisations and their people to achieve more. He focuses on inspiring leaders, evolving cultures and ways of working, and building the operating models, governance and capabilities needed to move from experimentation to scalable adoption. By connecting technology with strategy, customer engagement and disciplined value realisation, he empowers teams to turn new possibilities into meaningful impact for customers, patients and the business.